Human immunodeficiency virus (HIV) remains a major public health concern despite a large education effort during the past 25 years. A persistent problem with HIV infection is the high comorbity rate of clinical depression. We previously established that increasing proinflammatory cytokines within the brain of mice induces sickness that can culminate in depressive-like behavior. Here we investigated the role of the HIV transactivator of transcription (Tat) protein in activation of brain cytokine signaling and subsequent induction of depressive-like behavior in a murine model. Adult Balb/c mice were administered a single intracerebroventricular (ICV) injection of Tat (40 ng). Social investigation of a novel juvenile was measured at 2, 4, 8 and 24 h post-treatment. Mice treated with Tat did not display signs of sickness, as measured by either decreased social investigation or loss of body weight. At 24 h post-injection, mice were subjected to the forced swim test (FST). ICV administration of Tat to Balb/c mice increased immobility in the FST at 24 h post injection. A different strain of mice, C57BL/6J, responded similarly in the FST. Furthermore, adult C57BL/6J mice injected with Tat and tested in a two-bottle 1% sucrose preference test displayed reduced preference for sucrose during the 24 h post-injection period. Subsequently, brain tissues from Tat-treated and control C57BL/6J mice were collected at 4 and 24 h post injection. CNS tissue from Tat-treated mice had increased expression of IL-1b, TNF-a, IL-6, and IDO mRNAs at 4 h post injection. These data demonstrate that a single exposure to Tat in the brain is sufficient to induce brain cytokine signaling that culminates in depressive-like behavior. The results reveal a potential role for Tat in the development of comorbid depression in HIV-infected individuals.
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Introduction
Human immunodeficiency virus (HIV) infection remains highly prevalent in the developed world despite significant public education efforts. The Center for Disease Control estimates that approximately 1 million people are living with HIV infections or acquired immunodeficiency syndrome (AIDS) in the United States with the rate of new infections remaining stable (CDC.gov). Comorbid depression is a significant problem among the HIV infected population because these subjects have a higher incidence rate of depression than the general population (Olatunji et al., 2006) . Of note, the population of individuals living with HIV infection continues to increase even with the advent of highly active antiretroviral therapy, which significantly increases the life expectancy. HIV infections with comorbid depression will likely increase as HIV treatments continue to improve.
A hallmark of HIV infection is its migration to the brain, initiating a neuro inflammatory response that contributes to the loss of neurons and AIDS dementia complex (Merrill and Chen, 1991) . Immune responses in the brain during HIV infection are engaged early during infection. Infected macrophages enter the brain in low abundance during early HIV infection and activate microglial cells to initiate the production and release of cytokines (Gendelman et al., 1994) . Microglia and astrocytes activated by surrounding HIV-infected cells respond with secretion of chemokines and cytokines that contribute to HIV associated dementia (Kaul et al., 2005) . HIV proteins also activate macrophage-like cells in the brain, including perivascular macrophages and microglia (Rappaport et al., 1999; Kaul et al., 2001; Pu et al., 2003) . The event triggers a proinflammatory cascade that ultimately leads to increased proinflammatory cytokine expression in the brain.
